Fiche centre
Instituto Alexander Fleming ( Site 0105)
Ciudad Autónoma de Buenos Aires — Argentina
Essais liés2clinical trials
VilleCiudad Autónoma de Buenos Aireslocalisation
PaysArgentinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07634471
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MK-1045 | Cancer | Phase 2/3 | NCT07634471 | A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | RECRUITING |
| Pembrolizumab | Parkinson | Phase 3 | NCT06952504 | A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) | RECRUITING |